JPRN-UMIN000051084招募中Unknown
Exploration of Biomarkers for AFP-PIVKA-II Double-Negative Cases in Hepatocellular Carcinoma - Exploration of Biomarkers for AFP-PIVKA-II Double-Negative Cases in Hepatocellular Carcinoma
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 530
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients whose consent is to be obtained in writing 1) Patients with primary tumors of other organs 2) PIVKA-II false positive patients with elevated PIVKA-II due to taking warfarin or using antibiotics within 1 month, or PIVKA-II false negative patients on vitamin K replacement therapy Opt-out patients 1) Patients with primary tumors of other organs 2) PIVKA-II false-positive patients with elevated PIVKA-II due to taking warfarin or using antibiotics within a month, or PIVKA-II false-negative patients on vitamin K replacement therapy 3) Patients who have refused to allow the use of data collected from their medical information records.
研究者
相似试验
Unknown
不适用
Study of PIVKA-II and AFP Measurement in Surveillance Program for Early Detection of Hepatocellular CarcinomaHepatocellular CarcinomaNCT01277653Yonsei University1,000
尚未招募
不适用
Assessment of AFP and PIVKA-II as Prognostic Indicators in Liver Transplantation for Hepatocellular CarcinomaLiver TransplantationAlpha-FetoproteinProtein Induced by Vitamin K Absence or Antagonist-IIHepatocellular CarcinomaNCT06331260Zhejiang University600
已完成
不适用
Evaluation of Novel Biomarkers from Acutely Ill Patients at Risk for Acute Kidney InjuryN17Acute renal failureDRKS00003499Astute Medical, Inc. VP, Clinical & Regulatory Strategy889
进行中（未招募）
1 期
A study to assess how ALZ-801 affects laboratory tests and symptoms of Alzheimer’s disease in patients who have a specific genotype (APOE4).EUCTR2020-000986-17-CZAlzheon Inc.85
已完成
不适用
Biomarker analysis: Phase II study of nivolumab + abemaciclib + endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer (NEWFLAME) WJOG11418B-TRHormone receptor positive and HER2-negative advanced breast cancerJPRN-UMIN000036970West Japan Oncology Group53